Industry / Pharmaceuticals: Major
Latest filings
10-K
2020 FY
LWEL
Luckwel Pharmaceuticals
10 Jun 21
Annual report
5:20pm
8-K
LWEL
Luckwel Pharmaceuticals
26 May 21
Entry into a Material Definitive Agreement
10:09am
10-Q
2021 Q3
PCYN
Procyon
24 May 21
Quarterly report
2:52pm
NT 10-Q
PCYN
Procyon
17 May 21
Notice of late quarterly filing
4:39pm
10-Q
2021 Q3
PPCB
Propanc Biopharma
14 May 21
Quarterly report
5:25pm
8-K
PCYN
Procyon
13 May 21
Completion of Acquisition or Disposition of Assets
5:29pm
8-K
LWEL
Luckwel Pharmaceuticals
27 Apr 21
Entry into a Material Definitive Agreement
7:47am
SC TO-T/A
MRK
Merck Sharp & Dohme
1 Apr 21
Third party tender offer statement (amended)
8:37am
SC TO-T/A
MRK
Merck Sharp & Dohme
22 Mar 21
Third party tender offer statement (amended)
4:31pm
8-K
LWEL
Luckwel Pharmaceuticals
21 Mar 21
Entry into a Material Definitive Agreement
8:00pm
News
Atea Pharma Secures AT-527-Related Milestone Payment Of $50M From Roche
AVIR
RHHBF
RHHVF
16 Jun 21
JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia Patients
ABBV
JNJ
RHHBF
14 Jun 21
AbbVie-Roche's Venclexta Shows Progression-Free Survival Of 74% In CLL Patients After Three Years Treatment
ABBV
RHHBF
RHHVF
11 Jun 21
Argenx Regains Global Rights from Johnson & Johnson to Blood Cancer Candidate Cusatuzumab
ABBV
ARGX
JNJ
7 Jun 21
Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer
RHHBF
RHHVF
SURF
4 Jun 21
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout
AMYT
BCRX
BCTX
3 Jun 21
Amryt Pharma's Oleogel-S10 Application Gets FDA Priority Review Tag for Skin Blistering Disorder
AMYT
3 Jun 21
Amryt Announces FDA Acceptance Of New Drug Application For Oleogel-S10 For Treatment Of Epidermolysis Bullosa
AMYT
2 Jun 21
Sutro Biopharma Receives Undisclosed Milestone Payment Under Bispecific ADC Collaboration with Merck
MKGAF
STRO
1 Jun 21
Biogen, Bio-Thera's Biosimilar Referencing Tocilizumab Meets Primary Endpoints In Late-Stage Study
BIIB
RHHBF
RHHVF
1 Jun 21
Press releases
Amryt Pharma Announces Filing of Preliminary Registration Statement on Form F-4 in Connection with Its Proposed Acquisition of Chiasma, Inc.
AMYT
CHMA
15 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
AMYT
3 Jun 21
Proactive news headlines including Sigma Lithium Resources, Royal Road Minerals, Western Magnesium and Marvel Discovery
AMYT
BETRF
BYRN
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
AMYT
2 Jun 21
Merck KGaA to Host Earnings Call
MKGAF
12 May 21
CHIASMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chiasma, Inc. - CHMA
AMYT
CHMA
7 May 21
CHIASMA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CHMA and Encourages Investors to Contact the Firm
AMYT
CHMA
6 May 21
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc.
AMYT
CHMA
5 May 21
SHAREHOLDER ALERT: WeissLaw LLP Investigates Chiasma, Inc.
AMYT
CHMA
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
AMYT
CHMA
5 May 21
Reddit threads
Want to invest in biotech? A quick guide.
MBIO
VKTX
ATOS
22 May 21
SCHY: Top Ten Holdings Payout Ratios
UL
BHP
RHHBF
9 May 21
Daily Discussion Thread - May 5th, 2021
AAWW
ABC
ABEO
5 May 21
Daily Discussion Thread - May 4th, 2021
BARK
ACLS
ACRE
4 May 21
Daily Discussion Thread - May 3rd, 2021
AMOT
BRBS
CIG
3 May 21
Allena Pharma DD($ALNA)
ALNA
RARX
ITCI
15 Apr 21
Decided to cut my losses with SYN, ASRT, and CTRM. Went all in CTXR. Had 1000 @ 1.53 before buying another 3000@ 2.10
SYN
ASRT
CTRM
24 Mar 21
Wall Street Week Ahead for the trading week beginning March 22nd, 2021
GME
BNGO
BLNK
20 Mar 21
$SLNO may be a really savvy buy right now
SLNO
TA
IH
12 Mar 21
$OPGN OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 Pneumonia
OPGN
PSB
ASTS
8 Mar 21
Transcripts
LQDA
2020 Q4
Earnings call transcript
23 Mar 21
MKGAF
2020 Q3
Earnings call transcript
13 Nov 20
LQDA
2020 Q3
Earnings call transcript
9 Nov 20
LQDA
2020 Q2
Earnings call transcript
10 Aug 20
AMAG
2020 Q2
Earnings call transcript
9 Aug 20
LQDA
2020 Q1
Earnings call transcript
11 May 20
AMAG
2020 Q1
Earnings call transcript
11 May 20
LQDA
2019 Q4
Earnings call transcript
11 Mar 20
AMAG
2019 Q4
Earnings call transcript
4 Mar 20
LQDA
2019 Q3
Earnings call transcript
13 Nov 19
Patents
GRANT
Design
Packaging
MKGAF
15 Jun 21
APP
Utility
Tyrosine Kinase Inhibitors
PRNB
10 Jun 21
APP
Utility
Anti-sirp-alpha Antibodies and Related Methods
FTSV
10 Jun 21
APP
Utility
Cyclic Polypeptides for PCSK9 Inhibition
MRK
3 Jun 21
GRANT
Utility
Modulation of complement activity
RARX
25 May 21
APP
Utility
Processes for Preparing an FGFR Inhibitor
PRNB
20 May 21
APP
Utility
ANTI-CD47 Based Treatment of Blood Cancer
FTSV
20 May 21
APP
Utility
Humanized Antibodies Against C-kit
FTSV
29 Apr 21
APP
Utility
Modified Release Formulations of 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE
PRNB
22 Apr 21
APP
Utility
Combination Therapies for Treating Myelodysplastic Syndromes and Acute Myeloid Leukemia
FTSV
22 Apr 21